In summary, our findings provide novel mechanistic insights into how TRAF3 functions as a critical immune checkpoint in myeloid cells to restrain MDSC expansion, thereby preventing overzealous inflammation and indirectly promoting anti-tumor immunity. The gene discussed is TRAF3; the disease is neoplasm.